Research output per year
Research output per year
Research output
- 4 Article
-
DLBCL 1L-What to Expect beyond R-CHOP?
Stegemann, M., Denker, S. & Schmitt, C., 11 Mar 2022, In: Cancers. 14, 6, 1 p., 1453.Research output: Contribution to journal › Article › peer-review
Open Access -
ASH 2020 Highlights zu den aggressiven Non-Hodgkin Lymphomen
Schmitt, C. & Stegemann, M., Feb 2021, In: Spectrum Onkologie. 1 p.Research output: Contribution to journal › Article
-
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Ghanem, R., Stegemann, M., Klein, K., Pammer, M., Rauscher, I., Salzer, H., Doppler, S., Habringer, A., Paar, C., Kimeswenger, S., Hoetzenecker, W., Lamprecht, B., Lee, S. & Schmitt, C., Sept 2021, In: Cancer Cell. 39, 9, p. 1171-1172 2 p.Research output: Contribution to journal › Article › peer-review
-
The next big thing? – Bispezifische Antikörper erobern die Hämato-Onkologie
Schmitt, C. & Stegemann, M., May 2021, In: Onkologie und Hämatologie. 1 p.Research output: Contribution to journal › Article
-
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (ARGX-113-2402)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
04.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Phase III randomized, open-label, international, multicenter study evaluating the efficacy and safety of mosunetuzumab plus lenalidomide in comparison to anti- CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma (MorningLyte)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
02.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
AI prediction of PET positivity in CT scans (PET-KM-CTs)
Krivic, D. (Researcher), Stegemann, M. (PI), Lichtenauer, N. (Researcher), Fuchs, P. (Researcher), Fellner, F. (Researcher), Kronbichler, J. (Researcher), Gabriel, M. (Researcher) & Kobler, E. (Researcher)
01.04.2025 → 31.03.2029
Project: Clinical studies › Clinical Study (Academic - no third-party funds)
-
AGMT Metastasic Colorectal Cancer Registry (mCRC) Third Line and Beyond (mCRC Registry)
Krivic, D. (Researcher), Piringer, G. (PI), Lichtenauer, N. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
20.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery (MK-2870-012)
Krivic, D. (Researcher), Preuß, C. I. (PI), Schwarz, H. K. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher), Trathnigg, N. (Researcher) & Lichtenauer, N. (Researcher)
18.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Simultaneous auto-transplant and CD19 CAR T-cell 2L therapy followed by a CD20 x CD3 bispecific antibody in a patient with refractory Burkitt lymphoma
Stegemann, M. (Speaker)
03 Dec 2024Activity: Talk or presentation › Poster presentation › science-to-science
-
T-NHL
Stegemann, M. (Speaker)
01 Nov 2024Activity: Talk or presentation › Contributed talk › science-to-science
-
Aggressive und indolente NHL
Stegemann, M. (Speaker)
22 Oct 2024Activity: Talk or presentation › Contributed talk › science-to-science
-
Bispezifische Antikörper - worauf es in der Pflege ankommt
Stegemann, M. (Speaker)
22 Oct 2024Activity: Talk or presentation › Other talk or presentation › science-to-public
-
Elucidating the senolytic capacity of Obinutuzumab in chemotherapy-exposed human DLBCL cell lines
Stegemann, M. (Speaker)
04 Jun 2024Activity: Talk or presentation › Poster presentation › science-to-science